456 related articles for article (PubMed ID: 21707225)
61. Treatment with recombinant human erythropoietin in children with malignancies.
Bolonaki I; Stiakaki E; Lydaki E; Dimitriou H; Kambourakis A; Kalmantis T; Kalmanti M
Pediatr Hematol Oncol; 1996; 13(2):111-21. PubMed ID: 8721025
[TBL] [Abstract][Full Text] [Related]
62. Optimising anaemia management with epoetin beta.
Reed N; Morère JF
Oncology; 2004; 67 Suppl 1():12-6. PubMed ID: 15486448
[TBL] [Abstract][Full Text] [Related]
63. Erythropoietin treatment in chemotherapy-induced anemia in previously untreated advanced esophagogastric cancer patients.
Thomaidis T; Weinmann A; Sprinzl M; Kanzler S; Raedle J; Ebert M; Schimanski CC; Galle PR; Hoehler T; Moehler M;
Int J Clin Oncol; 2014 Apr; 19(2):288-96. PubMed ID: 23532629
[TBL] [Abstract][Full Text] [Related]
64. Recombinant human erythropoietin in the anemia associated with multiple myeloma or non-Hodgkin's lymphoma: dose finding and identification of predictors of response.
Cazzola M; Messinger D; Battistel V; Bron D; Cimino R; Enller-Ziegler L; Essers U; Greil R; Grossi A; Jäger G; LeMevel A; Najman A; Silingardi V; Spriano M; van Hoof A; Ehmer B
Blood; 1995 Dec; 86(12):4446-53. PubMed ID: 8541533
[TBL] [Abstract][Full Text] [Related]
65. Recombinant human erythropoietin in very elderly patients with myelodysplastic syndromes: results from a retrospective study.
Tatarelli C; Piccioni AL; Maurillo L; Naso V; Battistini R; D'Andrea M; Criscuolo M; Nobile C; Villivà N; Mancini S; Neri B; Breccia M; Fenu S; Buccisano F; Voso MT; Latagliata R; Aloe Spiriti MA
Ann Hematol; 2014 Aug; 93(8):1413-20. PubMed ID: 24647684
[TBL] [Abstract][Full Text] [Related]
66. Prospective study of erythropoietin use on quality of life and cost effectiveness in acute myeloid leukemia and allogeneic hematopoietic stem cell transplantation patients.
Michallet M; Goldet K; Sobh M; Morisset S; Chelghoum Y; Thomas X; Barraco F; Ducastelle S; Labussière H; Renzullo C; Paillet C; Pivot C; Straaten PB; Denis A; Termoz A; Detrait M; Nicolini FE; Jaisson-Hot I
Cancer; 2013 Jan; 119(1):107-14. PubMed ID: 22744794
[TBL] [Abstract][Full Text] [Related]
67. Efficacy and safety of iorEPOCIM for chemotherapy- or radiotherapy-induced anemia in pediatric cancer patients.
Vargas A; Mendoza I; Uranga R; González A; Martínez L; Caballero I; Piedra P; Saurez G; Verdecia M; Cabanas R
MEDICC Rev; 2010 Jul; 12(3):27-31. PubMed ID: 20697335
[TBL] [Abstract][Full Text] [Related]
68. Erythropoietic therapy for the treatment of anemia in patients with cancer: a valuable clinical and economic option.
Cornes P; Coiffier B; Zambrowski JJ
Curr Med Res Opin; 2007 Feb; 23(2):357-68. PubMed ID: 17288690
[TBL] [Abstract][Full Text] [Related]
69. Efficacy of Erythropoietin-Beta Injections During Autologous Blood Donation Before Spinal Deformity Surgery in Children and Teenagers.
Ikegami S; Takahashi J; Kuraishi S; Shimizu M; Futatsugi T; Uehara M; Horiuchi K; Shimodaira S; Kato H
Spine (Phila Pa 1976); 2015 Nov; 40(21):E1144-9. PubMed ID: 26502101
[TBL] [Abstract][Full Text] [Related]
70. Therapeutic superiority and safety of combined hydroxyurea with recombinant human erythropoietin over hydroxyurea in young β-thalassemia intermedia patients.
Elalfy MS; Adly AA; Ismail EA; Elhenawy YI; Elghamry IR
Eur J Haematol; 2013 Dec; 91(6):522-33. PubMed ID: 23927461
[TBL] [Abstract][Full Text] [Related]
71. Use of nandrolone decanoate as an adjuvant for erythropoietin dose reduction in treating anemia in patients on hemodialysis.
Sheashaa H; Abdel-Razek W; El-Husseini A; Selim A; Hassan N; Abbas T; El-Askalani H; Sobh M
Nephron Clin Pract; 2005; 99(4):c102-6. PubMed ID: 15703460
[TBL] [Abstract][Full Text] [Related]
72. Clinical and in vitro effects of recombinant human erythropoietin in patients receiving intensive chemotherapy for small-cell lung cancer.
de Campos E; Radford J; Steward W; Milroy R; Dougal M; Swindell R; Testa N; Thatcher N
J Clin Oncol; 1995 Jul; 13(7):1623-31. PubMed ID: 7602351
[TBL] [Abstract][Full Text] [Related]
73. Efficacy of erythropoietin administration in the treatment of anemia immediately after renal transplantation.
Van Biesen W; Vanholder R; Veys N; Verbeke F; Lameire N
Transplantation; 2005 Feb; 79(3):367-8. PubMed ID: 15699772
[TBL] [Abstract][Full Text] [Related]
74. Erythropoietin treatment in metastatic breast cancer--effects on Hb, quality of life and need for transfusion.
Olsson AM; Svensson JH; Sundström J; Bergström S; Edekling T; Carlsson G; Hansen J; Svensson B; Albertsson M
Acta Oncol; 2002; 41(6):517-24. PubMed ID: 12546524
[TBL] [Abstract][Full Text] [Related]
75. Recombinant human erythropoietin in combination with chemotherapy increases breast cancer metastasis in preclinical mouse models.
Hedley BD; Chu JE; Ormond DG; Beausoleil MS; Boasie A; Allan AL; Xenocostas A
Clin Cancer Res; 2011 Oct; 17(19):6151-62. PubMed ID: 21856770
[TBL] [Abstract][Full Text] [Related]
76. Management of late anemia in Rhesus hemolytic disease: use of recombinant human erythropoietin (a pilot study).
Ovali F; Samanci N; Dağoğlu T
Pediatr Res; 1996 May; 39(5):831-4. PubMed ID: 8726237
[TBL] [Abstract][Full Text] [Related]
77. The effect of subcutaneous r-HuEPO in cancer patients receiving chemotherapy with anemia: a preliminary report.
Chiou TJ; Chim YS; Wei CH; Hsieh RK; Chen PM
Zhonghua Yi Xue Za Zhi (Taipei); 1997 Nov; 60(5):229-35. PubMed ID: 9509677
[TBL] [Abstract][Full Text] [Related]
78. [Treatment of anaemia of prematurity with SS-R-Hu-erythropoietin and significance of hypoxia-inducible factor].
Pramatarova T; Sluncheva B; Jarukova N; Vakrilova L; Emilova Z; Shishkova R; Dimitrov A; Nikolov A; Radulova P; Chitrova S
Akush Ginekol (Sofiia); 2010; 49(1):11-7. PubMed ID: 20734660
[TBL] [Abstract][Full Text] [Related]
79. Management of anemia in patients undergoing curative radiotherapy. Erythropoietin, transfusions, or better nothing?
Dunst J
Strahlenther Onkol; 2004 Nov; 180(11):671-81. PubMed ID: 15549184
[TBL] [Abstract][Full Text] [Related]
80. Recombinant human erythropoietin therapy for anemic cancer patients on combination chemotherapy.
Case DC; Bukowski RM; Carey RW; Fishkin EH; Henry DH; Jacobson RJ; Jones SE; Keller AM; Kugler JW; Nichols CR
J Natl Cancer Inst; 1993 May; 85(10):801-6. PubMed ID: 8487324
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
